I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 6 studies | 51% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 6 studies | 51% ± 20% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| muscle | 100% | 243110.85 | 803 / 803 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.16 | 1 / 1 |
| heart | 100% | 50514.02 | 859 / 861 | 0% | 0 | 0 / 0 |
| liver | 1% | 5.66 | 2 / 226 | 68% | 2.57 | 275 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 22% | 9.85 | 10 / 45 |
| prostate | 9% | 972.01 | 21 / 245 | 12% | 8.56 | 58 / 502 |
| ovary | 1% | 7.42 | 2 / 180 | 14% | 0.39 | 61 / 430 |
| kidney | 0% | 0 | 0 / 89 | 12% | 0.49 | 105 / 901 |
| skin | 1% | 76.16 | 24 / 1809 | 10% | 0.25 | 46 / 472 |
| pancreas | 1% | 4.62 | 2 / 328 | 9% | 0.17 | 16 / 178 |
| brain | 1% | 7.09 | 19 / 2642 | 5% | 0.10 | 37 / 705 |
| uterus | 0% | 0 | 0 / 170 | 6% | 0.41 | 27 / 459 |
| intestine | 1% | 10.10 | 9 / 966 | 5% | 0.08 | 26 / 527 |
| lung | 1% | 54.50 | 8 / 578 | 4% | 0.18 | 48 / 1155 |
| stomach | 0% | 3.58 | 1 / 359 | 4% | 0.08 | 12 / 286 |
| breast | 2% | 79.94 | 10 / 459 | 1% | 0.34 | 15 / 1118 |
| esophagus | 2% | 78.57 | 25 / 1445 | 2% | 0.03 | 3 / 183 |
| peripheral blood | 3% | 105.77 | 30 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 3% | 331.65 | 43 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 2% | 84.22 | 14 / 653 | 1% | 0.47 | 4 / 605 |
| adipose | 2% | 33.19 | 25 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 9.07 | 2 / 258 | 0% | 0 | 0 / 230 |
| bladder | 0% | 0 | 0 / 21 | 0% | 0.01 | 2 / 504 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| GO_0071691 | Biological process | cardiac muscle thin filament assembly |
| GO_0008150 | Biological process | biological_process |
| GO_0005916 | Cellular component | fascia adherens |
| GO_0005927 | Cellular component | muscle tendon junction |
| GO_0030018 | Cellular component | Z disc |
| GO_0017166 | Molecular function | vinculin binding |
| GO_0003779 | Molecular function | actin binding |
| GO_0051371 | Molecular function | muscle alpha-actinin binding |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | NRAP |
| Protein name | NRAP protein (Nebulin-related anchoring protein) Nebulin-related-anchoring protein (N-RAP) LIM and SH3 domain protein 1 Nebulin related anchoring protein |
| Synonyms | |
| Description | FUNCTION: May be involved in anchoring the terminal actin filaments in the myofibril to the membrane and in transmitting tension from the myofibrils to the extracellular matrix. . FUNCTION: Plays an important role in the regulation of dynamic actin-based, cytoskeletal activities. Agonist-dependent changes in LASP1 phosphorylation may also serve to regulate actin-associated ion transport activities, not only in the parietal cell but also in certain other F-actin-rich secretory epithelial cell types. . |
| Accessions | ENST00000369358.8 A0A0A0MRM2 A0AVL2 ENST00000360478.7 [Q86VF7-4] Q05D68 Q86VF7 ENST00000369360.7 [Q86VF7-3] ENST00000359988.4 [Q86VF7-1] |
